Cryoport, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cryoport, Inc. on September 27, 2013, covering events occurring between September 27 and October 3, 2013. The filing details the entry into material definitive agreements regarding the conversion of outstanding debt into equity.
Key Financial Metrics and Transaction Details
The filing does not provide standard financial metrics such as revenue, profit, cash flow, or operating margins. The primary financial activity reported is a debt-for-equity exchange:
- Total Debt Converted: $4,127,202 (aggregate principal and interest).
- Equity Issued: 20,636,011 Units.
- Conversion Price: $0.20 per Unit.
- Unit Composition: One share of Common Stock and one warrant to purchase one share of Common Stock.
- Warrant Terms: Exercise price of $0.37 per share; exercisable beginning March 31, 2014; five-year term.
- Related Party Conversions: Includes $101,945 held by Director Richard G. Rathmann and $202,740 held by GBR Investments, LLC (managed by Mr. Rathmann).
- Director Fee Conversions: Directors Stephen Wasserman and Richard G. Rathmann converted $20,000 and $24,556 of accrued board fees, respectively, into 100,000 and 122,778 Units.
- Placement Agent Compensation: Emergent Financial Group, Inc. received a warrant to purchase 1,911,259 shares at $0.20 per share as part of the original note issuance; no additional compensation was paid for this specific conversion.
Material Changes Versus Prior Period
The filing does not provide comparative financial data against a prior period. The material change is the reduction of outstanding unsecured convertible promissory notes and the corresponding increase in the company's share count and warrant obligations.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or specific risk factors beyond the standard disclosure that the summary is qualified by reference to the full text of the Exchange Documents. The securities were issued pursuant to exemptions under Rule 505/506 of Regulation D and Section 4(2) of the Securities Act of 1933.
Key Facts for Investor Verification
- Verify the exact number of shares and warrants outstanding post-conversion in the upcoming Form 10-Q for the quarter ended September 30, 2013.
- Confirm the dilution impact of the 20,636,011 new Units and the placement agent warrant on existing shareholders.
- Review the full text of the Exchange Documents filed as exhibits to the Form 10-Q for complete terms and conditions.
- Monitor the company's liquidity position following the conversion of $4.1 million in debt to equity.